Antioxidative nanofullerol inhibits macrophage activation and development of osteoarthritis in rats

References

• de Lange-Brokaar BJ, Ioan-Facsinay A, van Osch GJ, et al. Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthritis Cartilage/OARS Osteoarthritis Res Soc. 2012;20(12):1484–1499. doi:10.1016/j.joca.2012.08.027
   PubMed Web of Science ®Google Scholar
• Kandahari AMYX, Dighe AS, Pan D, Cui Q. Recognition of immune response for the early diagnosis and treatment of osteoarthritis. J Immunol Res. 2015;2015(2015):1–13. doi:10.1155/2015/192415
   Google Scholar
• Kroto HW, Heath JR, Obrien SC, Curl RF, Smalley RE. C-60 – buckminsterfullerene. Nature. 1985;318(6042):162–163. doi:10.1038/318162a0
   Web of Science ®Google Scholar
• Krusic PJ, Wasserman E, Keizer PN, Morton JR, Preston KF. Radical reactions of C60. Science. 1991;254(5035):1183–1185. doi:10.1126/science.254.5035.118317776407
   PubMed Web of Science ®Google Scholar
• Mcewen CN, Mckay RG, Larsen BS. C-60 as a radical sponge. J Am Chem Soc. 1992;114(11):4412–4414. doi:10.1021/ja00037a064
   Web of Science ®Google Scholar
• Yang X, Ebrahimi A, Li J, Cui Q. Fullerene-biomolecule conjugates and their biomedicinal applications. Int J Nanomedicine. 2014;9:77–92. doi:10.2147/IJN.S5282924379667
   PubMed Web of Science ®Google Scholar
• Emre Y, Hurtaud C, Karaca M, Nubel T, Zavala F, Ricquier D. Role of uncoupling protein UCP2 in cell-mediated immunity: how macrophage-mediated insulitis is accelerated in a model of autoimmune diabetes. Proc Natl Acad Sci USA. 2007;104(48):19085–19090. doi:10.1073/pnas.070955710418006654
   PubMedGoogle Scholar
• Bognar E, Sarszegi Z, Szabo A, et al. Antioxidant and anti-inflammatory effects in RAW264.7 macrophages of malvidin, a major red wine polyphenol. PLoS One. 2013;8(6):e65355. doi:10.1371/journal.pone.006535523755222
   PubMed Web of Science ®Google Scholar
• Gupta P, Srivastav S, Saha S, Das PK, Ukil A. Leishmania donovani inhibits macrophage apoptosis and pro-inflammatory response through AKT-mediated regulation of beta-catenin and FOXO-1. Cell Death Differ. 2016;23(11):1815–1826. doi:10.1038/cdd.2016.10127662364
   PubMedGoogle Scholar
• Yang Y, Kim SC, Yu T, et al. Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses. Mediators Inflamm. 2014;2014:352371. doi:10.1155/2014/35237124771982
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.126211846609
   PubMed Web of Science ®Google Scholar
• Nakanishi-Matsui M, Yano S, Matsumoto N, Futai M. Lipopolysaccharide induces multinuclear cell from RAW264.7 line with increased phagocytosis activity. Biochem Biophys Res Commun. 2012;425(2):144–149. doi:10.1016/j.bbrc.2012.07.05022820190
   PubMed Web of Science ®Google Scholar
• Monteiro-Riviere NA, Linder KE, Inman AO, Saathoff JG, Xia XR, Riviere JE. Lack of hydroxylated fullerene toxicity after intravenous administration to female Sprague-Dawley rats. J Toxicol Environ Health Part A. 2012;75(7):367–373. doi:10.1080/15287394.2012.67089422524592
   PubMed Web of Science ®Google Scholar
• Li J, Takeuchi A, Ozawa M, Li XH, Saigo K, Kitazawa K. C-60 fullerol formation catalyzed by quaternary ammonium hydroxides. J Chem Soc Chem Comm. 1993;(23):1784–1785.
   Google Scholar
• Chiang LY, Upasani RB, Swirczewski JW, Soled S. Evidence of hemiketals incorporated in the structure of fullerols derived from aqueous acid chemistry. J Am Chem Soc. 1993;115(13):5453–5457. doi:10.1021/ja00066a014
   Web of Science ®Google Scholar
• Kovac T, Borisev I, Crevar B, et al. Fullerol C60(OH)24 nanoparticles modulate aflatoxin B1 biosynthesis in Aspergillus flavus. Sci Rep. 2018;8(1):12855. doi:10.1038/s41598-018-31305-930150708
   PubMedGoogle Scholar
• Jin L, Ding M, Oklopcic A, et al. Nanoparticle fullerol alleviates radiculopathy via NLRP3 inflammasome and neuropeptides. Nanomed. 2017;13(6):2049–2059. doi:10.1016/j.nano.2017.03.015
   PubMed Web of Science ®Google Scholar
• Arifa RDN, Paula TP, Madeira MFM, et al. The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan. Pharmacol Res. 2016;107:102–110. doi:10.1016/j.phrs.2016.03.00426987941
   PubMed Web of Science ®Google Scholar
• Yang X, Li CJ, Wan Y, Smith P, Shang G, Cui Q. Antioxidative fullerol promotes osteogenesis of human adipose-derived stem cells. Int J Nanomedicine. 2014;9:4023–4031. doi:10.2147/IJN.S6678525187705
   PubMedGoogle Scholar
• Yang X, Jin L, Yao L, Shen FH, Shimer AL, Li X. Antioxidative nanofullerol prevents intervertebral disk degeneration. Int J Nanomedicine. 2014;9:2419–2430. doi:10.2147/IJN.S6085324876775
   PubMed Web of Science ®Google Scholar
• Liu HJ, Yang XL, Zhang Y, Dighe A, Li XD, Cui QJ. Fullerol antagonizes dexamethasone-induced oxidative stress and adipogenesis while enhancing osteogenesis in a cloned bone marrow mesenchymal stem cell. J Orthop Res. 2012;30(7):1051–1057. doi:10.1002/jor.2205422570221
   PubMedGoogle Scholar
• Tang J, Chen Z, Sun B, et al. Polyhydroxylated fullerenols regulate macrophage for cancer adoptive immunotherapy and greatly inhibit the tumor metastasis. Nanomed. 2016;12(4):945–954. doi:10.1016/j.nano.2015.11.021
   PubMed Web of Science ®Google Scholar
• Chen YW, Hwang KC, Yen CC, Lai YL. Fullerene derivatives protect against oxidative stress in RAW 264.7 cells and ischemia-reperfused lungs. Am J Physiol Regul Integr Comp Physiol. 2004;287(1):R21–R26. doi:10.1152/ajpregu.00310.200315191925
   PubMed Web of Science ®Google Scholar
• Roy P, Bag S, Chakraborty D, Dasgupta S. Exploring the inhibitory and antioxidant effects of fullerene and fullerenol on ribonuclease A. ACS Omega. 2018;3(9):12270–12283. doi:10.1021/acsomega.8b0158430320292
   PubMedGoogle Scholar
• Hao T, Li J, Yao F, et al. Correction to injectable fullerenol/alginate hydrogel for suppression of oxidative stress damage in brown adipose-derived stem cells and cardiac repair. ACS Nano. 2018;12(10):10564. doi:10.1021/acsnano.8b0294630270620
   PubMedGoogle Scholar
• Li J, Lei R, Li X, et al. The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivo. Part Fibre Toxicol. 2018;15(1):5. doi:10.1186/s12989-018-0241-929343276
   PubMedGoogle Scholar
• Satoh M, Takayanag I. Pharmacological studies on fullerene (C-60), a novel carbon allotrope, and its derivatives. J Pharmacol Sci. 2006;100(5):513–518.16682790
   PubMed Web of Science ®Google Scholar
• David J, Nandakumar A, Muniroh M, Akiba S, Yamamoto M, Koriyama C. Suppression of methylmercury-induced MIP-2 expression by N-acetyl-L-cysteine in murine RAW264.7 macrophage cell line. Eur J Med Res. 2017;22(1):45. doi:10.1186/s40001-017-0287-429122013
   PubMedGoogle Scholar
• Murakami Y, Kawata A, Ito S, Katayama T, Fujisawa S. The radical scavenging activity and cytotoxicity of resveratrol, orcinol and 4-allylphenol and their inhibitory effects on cox-2 gene expression and Nf-kappab activation in RAW264.7 cells stimulated with porphyromonas gingivalis-fimbriae. In Vivo. 2015;29(3):341–349.25977379
   PubMed Web of Science ®Google Scholar
• Yang X, Chordia MD, Du X, et al. Targeting formyl peptide receptor 1 of activated macrophages to monitor inflammation of experimental osteoarthritis in rat. J Orthopaedic Res. 2016;34(9):1529–1538. doi:10.1002/jor.23148
   PubMed Web of Science ®Google Scholar
• Cinar BM, Ozkoc G, Bolat F, Karaeminogullari O, Sezgin N, Tandogan RN. Intra-articular zoledronic acid in a rat osteoarthritis model: significant reduced synovitis may indicate chondroprotective effect. Knee Surg Sports Traumatol Arthroscopy. 2015;23(5):1410–1418. doi:10.1007/s00167-014-2955-z
   PubMed Web of Science ®Google Scholar
• Nam J, Perera P, Liu J, et al. Sequential alterations in catabolic and anabolic gene expression parallel pathological changes during progression of monoiodoacetate-induced arthritis. PLoS One. 2011;6(9):e24320. doi:10.1371/journal.pone.002432021931681
   PubMed Web of Science ®Google Scholar
• Udo M, Muneta T, Tsuji K, et al. Monoiodoacetic acid induces arthritis and synovitis in rats in a dose- and time-dependent manner: proposed model-specific scoring systems. Osteoarthritis Cartilage/OARS Osteoarthritis Res Soc. 2016;24(7):1284–1291. doi:10.1016/j.joca.2016.02.005
   PubMed Web of Science ®Google Scholar
• Lee J, Hong YS, Jeong JH, et al. Coenzyme Q10 ameliorates pain and cartilage degradation in a rat model of osteoarthritis by regulating nitric oxide and inflammatory cytokines. PLoS One. 2013;8(7):e69362. doi:10.1371/journal.pone.006936223894457
   PubMed Web of Science ®Google Scholar
• Wang ZM, Chen YC, Wang DP. Resveratrol, a natural antioxidant, protects monosodium iodoacetate-induced osteoarthritic pain in rats. Biomed Pharmacother. 2016;83:763–770. doi:10.1016/j.biopha.2016.06.05027484345
   PubMed Web of Science ®Google Scholar
• Yudoh K, Karasawa R, Masuko K, Kato T. Water-soluble fullerene (C60) inhibits the osteoclast differentiation and bone destruction in arthritis. Int J Nanomedicine. 2009;4:233–239.19918370
   PubMed Web of Science ®Google Scholar
• Yudoh K, Shishido K, Murayama H, et al. Water-soluble c60 fullerene prevents degeneration of articular cartilage in Osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development. Arthritis Rheum. 2007;56(10):3307–3318. doi:10.1002/art.2291717907184
   PubMedGoogle Scholar
• Castro RR, Cunha FQ, Silva FS Jr., Rocha FA. A quantitative approach to measure joint pain in experimental osteoarthritis–evidence of a role for nitric oxide. Osteoarthritis Cartilage/OARS Osteoarthritis Res Soc. 2006;14(8):769–776. doi:10.1016/j.joca.2006.01.013
   PubMed Web of Science ®Google Scholar
• Henrotin YE, Bruckner P, Pujol JP. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage/OARS Osteoarthritis Res Soc. 2003;11(10):747–755. doi:10.1016/S1063-4584(03)00150-X
   PubMed Web of Science ®Google Scholar
• Kurz B, Lemke A, Kehn M, et al. Influence of tissue maturation and antioxidants on the apoptotic response of articular cartilage after injurious compression. Arthritis Rheum. 2004;50(1):123–130. doi:10.1002/art.1143814730608
   PubMedGoogle Scholar
• Orrenius S. Reactive oxygen species in mitochondria-mediated cell death. Drug Metab Rev. 2007;39(2–3):443–455. doi:10.1080/0360253070146851617786631
   PubMed Web of Science ®Google Scholar
• Papathanassiu AE, Ko JH, Imprialou M, et al. BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases. Nat Commun. 2017;8:16040. doi:10.1038/ncomms1604028699638
   PubMed Web of Science ®Google Scholar
• Sugita R, Kuwabara H, Sugimoto K, et al. A novel selective prostaglandin E2 synthesis inhibitor relieves pyrexia and chronic inflammation in rats. Inflammation. 2016;39(2):907–915. doi:10.1007/s10753-016-0323-526923147
   PubMedGoogle Scholar
• Akasaki Y, Matsuda S, Nakayama K, Fukagawa S, Miura H, Iwamoto Y. Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation. Osteoarthritis Cartilage/OARS Osteoarthritis Res Soc. 2009;17(2):235–243. doi:10.1016/j.joca.2008.06.012
   PubMed Web of Science ®Google Scholar
• Mohan G, Perilli E, Parkinson IH, Humphries JM, Fazzalari NL, Kuliwaba JS. Pre-emptive, early, and delayed alendronate treatment in a rat model of knee osteoarthritis: effect on subchondral trabecular bone microarchitecture and cartilage degradation of the tibia, bone/cartilage turnover, and joint discomfort. Osteoarthritis Cartilage/OARS Osteoarthritis Res Soc. 2013;21(10):1595–1604. doi:10.1016/j.joca.2013.06.020
   PubMed Web of Science ®Google Scholar
• Huskisson EC, Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford). 1999;38(7):602–607.10461471
   PubMed Web of Science ®Google Scholar
• Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014;5(3):351–361. doi:10.5312/wjo.v5.i3.35125035839
   PubMedGoogle Scholar